ACRS News and Press, Aclaris Therapeutics Inc. From 12/06/23

2023-12-06 14:48:10 ET Penny Stocks – How News Makes These Small Caps Soar or Plunge Penny stocks , securities with share prices under $5, offer investors a chance at exponential returns with little upfront investment. However, investing wisely in penny stocks require...

2023-12-05 17:10:33 ET Penny stocks , defined as those trading under $5 per share, offer unique opportunities. With low prices and the potential for high percentage returns, it’s understandable why penny stocks attract interest from new traders. However, diving into penny...

2023-12-05 16:05:02 ET More on Aclaris Therapeutics Stocks To Watch: Nvidia, Lowe's, Deere And Best Buy Line Up To Report Aclaris Therapeutics: The Many Lives Of This Biopharmaceutical Developer Aclaris plummets as mid-stage trial for arthritis therapy fails ...

WAYNE, Pa., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drugs for immuno-inflammatory diseases, today announced an exclusive patent license agreement with Sun Pharmaceutical Industries, Inc. (S...

2023-11-18 10:30:00 ET Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports a...

2023-11-17 15:00:53 ET More on the markets SPY: Sell The Rally - Historical Patterns Show Misplaced Optimism S&P 500: Forget The Year-End Rally The Message From 12 Post-CPI Charts The 12 least expected market outcomes of '24 - and how to trade them ...

2023-11-13 12:36:46 ET Gainers: Tenax Therapeutics ( TENX ) +310% . Tivic Health Systems ( TIVC ) +71% . Montauk Renewables ( MNTK ) +28% . Sohu.com Ltd. ( SOHU ) +24% . INVO Bioscience ( INVO ) +26% . Direct Digital Holdings...

2023-11-13 10:00:16 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector a...

2023-11-13 08:22:15 ET Losers: Aclaris Therapeutics ( ACRS ) -85% announces top-line results from 12-Week phase 2b trial of Oral Zunsemetinib . Verve Therapeutics ( VERV ) -38% . Syntec Optics Holdings ( OPTX ) -10% . Motus GI Holdings ( MOTS ...

2023-11-13 07:56:03 ET More on Aclaris Aclaris Therapeutics: The Many Lives Of This Biopharmaceutical Developer Aclaris Therapeutics rises 13% on insider buy Seeking Alpha’s Quant Rating on Aclaris Therapeutics Historical earnings data for Aclaris Ther...